Catalan pharma firm announces breakthrough for first phases of Alzheimer's
Grífols claims clinical trial suggests reduction in disease's progression
Grífols claims clinical trial suggests reduction in disease's progression
Research center run by top Catalan cardiologist and US scientists make breakthrough that holds out hope for future treatment